JLE

Bulletin du Cancer

MENU

Hormone therapy for prostate cancer Volume 91, issue 1, Janvier 2004

Author
Institut Gustave‐Roussy, Département de médecine, 39, rue Camille‐Desmoulins, 94800 Villejuif

Hormonal deprivation has been used for more than 60 years in the treatment of advanced prostate cancer. However, the optimal form of this therapy is still an enigma. This review discusses some of the current challenges in the hormonal management of prostate cancer, regarding complete androgen blockade, intermittent treatment and the question of whether early hormonal deprivation is superior to delayed therapy. The choice of hormone therapy for cancer of the prostate depends not only on the desired progression free survival and overall survival but also an the patient‘s quality of life and on the treatment toxicities and costs. ▴